検索結果

April 6, 2026 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease throug...

事業所・子会社一覧 | 企業情報 | 千寿製薬株式会社

南町六丁目4番3 電話番号：078-777-1010 オキュラーサイエンス研究所 電話番号：078-777-1020 地図 海外 研究所・事務所 センジュ オキュラーサイエンス研究所・オレゴン研究室 SENJU LABORATORY OF OCULAR SCIENCES (SLOS) OTRADI Bioscience Incubator, 4640 S Macadam Ave., Suite 2...

論文投稿実績 | 研究開発活動 | 千寿製薬株式会社

2 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor College of Medicine, Houston, Texas, USA Amer...

Publications | Research & Development | SENJU Pharmaceutica

2 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor College of Medicine, Houston, Texas, USA Amer...

Research and Development System | Research & Development | SENJU Pharmaceutica

things in nature have a reason for being.Today’s common sense may not be common sense tomorrow. At Senju Pharmaceutical, we are dedicated not only to our original R&D initiatives but also to R&am...